Amanote Research
Register
Sign In
Comparison of Repaglinide and Nateglinide in Combination With Metformin: Response to Baron
Diabetes Care
- United States
doi 10.2337/diacare.26.12.3362
Full Text
Open PDF
Abstract
Available in
full text
Categories
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Date
November 21, 2003
Authors
P. Raskin
Publisher
American Diabetes Association
Related search
Comparison of Nateglinide and Gliclazide in Combination With Metformin, for Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Maximum Doses of Metformin Alone
Diabetic Medicine
Internal Medicine
Endocrinology
Metabolism
Diabetes
Repaglinide/Metformin Fixed-Dose Combination to Improve Glycemic Control in Patients With Type 2 Diabetes: An Update
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Updated Review: Improved Glycemic Control With Repaglinide-Metformin in Fixed Combination for Patients With Type 2 Diabetes
Clinical Medicine Insights: Endocrinology and Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Efficacy and Safety of Repaglinide vs Nateglinide for Treatment of Japanese Patients With Type 2 Diabetes Mellitus
Journal of Diabetes Investigation
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
Comparison of Antioxidative Effect of Metformin and Combination of Metformin-Sulfonylurea in Type 2 Diabetes Mellitus Patients
Journal of Young Pharmacists
Toxicology
Pharmaceutics
Pharmacology
State of the Art Paper the Role of Nateglinide and Repaglinide, Derivatives of Meglitinide, in the Treatment of Type 2 Diabetes Mellitus
Archives of Medical Science
Medicine
Comparative Study of the Antioxidant Effects of Metformin, Glibenclamide, and Repaglinide in Alloxan-Induced Diabetic Rats
Journal of Diabetes Research
Endocrinology
Metabolism
Diabetes
Short-Term Efficacy and Safety of Repaglinide Versus Glimepiride as Augmentation of Metformin in Treating Patients With Type 2 Diabetes Mellitus
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Prescribing Pattern of Gliclazide, Metformin and Combination Therapy With Insulin in UAE
Journal of Applied Pharmaceutical Science
Medicine
Toxicology
Pharmaceutics
Pharmacology